9th Nov 2007 15:59
Meldex International PLC09 November 2007 For Immediate Release 9 November 2007 Meldex International plc Notification of Shareholding London, UK, 9 November 2007: Meldex International plc (AIM: MDX) the specialtypharma and healthcare company, was notified today that Barclays PLC now has aninterest in 11,716,900 ordinary shares of 1p each in the Company representing6.08% of the shares of Meldex International Plc. - ENDS - For further information: Meldex International Plc + 44 (0) 20 7098 9881Richard Trevillion, CEOSteve Martin, CDOHiral Patel, CFO Buchanan Communications + 44 (0) 20 7466 5000Rebecca Skye DietrichMark Court About Meldex International Plc Meldex International plc is an innovative specialty pharmaceutical and OTCproduct Company. Listed on London's AIM in May 2003, the Company has over 80patents granted or in application within 24 patent families and has productdevelopment agreements and strategic alliances with several global healthcarecompanies. Meldex has acquired sales and marketing resources within Europe andthe US as a launch mechanism for its own pharmaceutical products. Meldexacquired the Melbrosin business in June 2007 for a consideration of up to €35m,Melbrosin's focus is on consumer over the counter health care products based onsubstances of natural and plant origin, which are developed into consumerorientated brands then scaled, produced and distributed by Melbrosin. TheMelbrosin complements the prescription pharmaceutical sales and marketingbusiness created and expanded in 2006. The business continues to develop innovative delivery mechanisms enhancing bothits own product range and those of selected partners using its proprietary XGELTM polymer technology. For further information please go towww.meldexinternational.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Barclays